Yale Catriona (CIK 0001779308)

Latest company ownership

AKRO - Akero Therapeutics, Inc.
Role: Chief Development Officer
Shares held
4,739
Last filed at
Nov 6, 2025
Confidence Score
42.7
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 11, 2025 Sep 12, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 48.8 -659 -0.72% ✗ $28.4K
Jul 16, 2025 Jul 18, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -10,000 -9.85% ✓ $529.5K
Jun 18, 2025 Jun 20, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 42.5 -1,633 -1.77% ✗ $89.6K
Jun 16, 2025 Jun 20, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -10,000 -9.78% ✓ $542.3K
Jun 10, 2025 Jun 12, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 42.5 -2,803 -2.95% ✗ $151.4K
May 15, 2025 May 19, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -10,000 -9.52% ✓ $393K
Apr 15, 2025 Apr 16, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -9,073 -8.72% ✓ $344K
Mar 17, 2025 Mar 18, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -10,000 -9.52% ✓ $447.6K
Mar 12, 2025 Mar 14, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 48.8 -614 -0.64% ✗ $27.6K
Feb 18, 2025 Feb 21, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -10,000 -9.47% ✓ $498.7K
Jan 27, 2025 Jan 31, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 5.0 -53,590 -35.91% ✓ $3M
Jan 27, 2025 Jan 31, 2025 Akero Therapeutics, Inc. Chief Development Officer Sell 5.0 -49,074 -33.91% ✓ $2.7M
Dec 16, 2024 Dec 18, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 92.5 +15,226 8.65% ✓ $264.1K
Dec 10, 2024 Dec 12, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 42.5 -2,810 -3.79% ✗ $86.5K
Nov 15, 2024 Nov 19, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 22.5 -9,061 -10.89% ✓ $251.3K
Nov 6, 2024 Nov 8, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 22.5 -10,000 -11.88% ✓ $351.9K
Oct 30, 2024 Nov 1, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 22.5 -20,000 -11.88% ✓ $652K
Oct 15, 2024 Oct 16, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -20,961 -8.52% ✓ $636.5K
Sep 20, 2024 Sep 23, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 32.5 -5,500 -6.81% ✓ $152.1K
Sep 16, 2024 Sep 18, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 37.5 -8,393 -3.58% ✓ $231.2K
Sep 10, 2024 Sep 13, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 48.8 -637 -0.84% ✗ $16.7K
Sep 3, 2024 Sep 5, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 48.8 -949 -1.23% ✓ $26.2K
Aug 23, 2024 Aug 28, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -14,051 -8.47% ✓ $386.7K
Jun 11, 2024 Jun 13, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 42.5 -2,825 -3.64% ✗ $64K
Mar 13, 2024 Mar 15, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 48.8 -723 -0.92% ✗ $20.5K
Mar 4, 2024 Mar 6, 2024 Akero Therapeutics, Inc. Chief Development Officer Sell 12.5 -20,646 -20.84% ✓ $732.7K
Dec 14, 2023 Dec 18, 2023 Akero Therapeutics, Inc. Chief Development Officer Sell 48.8 -597 -0.76% ✗ $12.4K
Sep 13, 2023 Sep 25, 2023 Akero Therapeutics, Inc. Chief Development Officer Sell 35.0 -5,617 -3.85% ✓ $271.4K
Aug 28, 2023 Aug 30, 2023 Akero Therapeutics, Inc. Chief Development Officer Sell 22.5 -5,745 -10.97% ✓ $287.2K
Jun 21, 2023 Jun 23, 2023 Akero Therapeutics, Inc. Chief Development Officer Sell 17.5 -33,349 -41.70% ✗ $1.7M
Jun 13, 2023 Jun 15, 2023 Akero Therapeutics, Inc. Chief Development Officer Sell 51.3 -591 -0.73% ✓ $32.6K
Mar 10, 2023 Mar 14, 2023 Akero Therapeutics, Inc. Chief Development Officer Sell 48.8 -701 -0.86% ✗ $30.5K
Jan 13, 2023 Jan 18, 2023 Akero Therapeutics, Inc. Chief Development Officer Sell 30.0 -5,000 -5.80% ✓ $252.7K
Dec 9, 2022 Dec 13, 2022 Akero Therapeutics, Inc. Chief Development Officer Sell 95.0 +14,195 19.70% ✓ $216.1K
Nov 10, 2022 Nov 14, 2022 Akero Therapeutics, Inc. Chief Development Officer Sell 32.5 -5,000 -6.49% ✓ $197.1K
Oct 10, 2022 Oct 12, 2022 Akero Therapeutics, Inc. Chief Development Officer Sell 32.5 -5,000 -6.09% ✓ $190K
Sep 13, 2022 Sep 15, 2022 Akero Therapeutics, Inc. Chief Development Officer Sell 5.0 -40,000 -32.77% ✓ $1.1M
Oct 15, 2021 Oct 18, 2021 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -12,500 -9.37% ✓ $269.8K
Sep 15, 2021 Sep 17, 2021 Akero Therapeutics, Inc. Chief Development Officer Sell 26.3 -12,500 -8.57% ✓ $308.6K
Aug 16, 2021 Aug 17, 2021 Akero Therapeutics, Inc. Chief Development Officer Sell 32.5 -10,000 -6.41% ✓ $187.9K
Jul 15, 2021 Jul 19, 2021 Akero Therapeutics, Inc. Chief Development Officer Sell 32.5 -10,000 -6.03% ✓ $209K